Introduction
Congenital central hypoventilation syndrome (CCHS) is caused by an abnormality in neural regulation of respiration. It manifests by normal or near normal ventilation during the wakeful state but by hypoventilation/apnea during sleep. In the normal state, respiration is initiated by rhythmicity of respiratory neurons (respiratory drive), modulated by reflex input from chemoreceptors in the aortic arch and carotid body, by stretch receptors in the airways and by input from higher CNS centers, including those that initiate sleep/wake cycles. Individuals with CCHS appear to lack intrinsic rhythmic discharge of respiratory neurons and respond inadequately or not at all to hypercapnia/hypoxemia. Left untreated, most affected individuals die early in life from respiratory arrest/hypoventilation during sleep.
1 Long-term survival has been reported in untreated individuals.
2 CCHS is associated with heterogeneous polyalanine expansions and framework mutations in the PHOX2b gene, 2, 3 inherited as an autosomal dominant condition of variable penetrance. 4, 5 We report here, the first case of prenatal diagnosis of a fetus with this condition. In addition, we have documented the incidence, frequency and character of fetal breathing movements in an affected fetus, observed the fetal effects of maternal hypercapnia and evaluated the relationship between sleep/wake cycles and the frequency and character of fetal breathing movements.
Case
In the index pregnancy, the mother was a 21-year-old primigravida with a planned pregnancy. She was diagnosed at 3 years of age with CCHS and shown to have a de novo PHOX2b mutation. She has been managed by rhythmic respiratory stimulation while awake, end tidal CO 2 monitoring, and mechanical ventilation through tracheostomy while sleeping. She reported no family history of CCHS. However, her father had late adult-onset sleep apnea requiring CPAP.
An ultrasound fetal examination at 18 weeks' gestation revealed normal anatomy, including thoracic dimensions and lung density. At 18 weeks' gestation, amniotic fluid and maternal venous blood samples were sent to the Department of Pediatrics at Rush University, Chicago, for analysis to determine the presence of the exon 3 polyalanine expansion mutation (PHOX2b). 3 The results revealed a female fetus with 26 alanine-coding triplet repeats for each PHOX2b allele, confirming CCHS. The fetal expansion coding number was identical to the maternal mutation. After extensive genetic counseling, the mother elected to continue the pregnancy. Fetal ultrasound examinations were performed monthly through 32 weeks and confirmed normal fetal growth, including thoracic dimensions and shape and mildly elevated amniotic fluid volume. At 32 weeks and thereafter, dynamic ultrasound was performed twice weekly and fetal breathing characteristics were studied in detail. Fetal breathing movements were present for at least 40% of the observed time (range 30 to 60 min) and were normal in frequency and character. Fetal breathing movements were characterized by episodes of isolated diaphragmatic excursions and combined diaphragmatic and intercostal breathing movements. The frequency characteristics of fetal breathing movements ranged from episodes of crescendo-decrescendo patterns, regular rhythmic breathing at a rate ranging from 15 to 40 breaths per minute and sporadic infrequent episodes of slow intermittent sighing-type breathing. Breathing episodes were associated with normal paradoxical laryngeal movements and periodic efflux of fluid from the nostrils. Fetal breathing movements were present for the majority of the time during rapid eye movements but occasionally present when rapid eye movements were absent. Transient maternal breath holding (90 s) during fetal apnea did not initiate fetal breathing. Transient maternal breath holding during fetal breathing episodes had no obvious effect on the frequency or character of fetal breathing movements.
Spontaneous labor and vaginal delivery occurred at 34 weeks. The female infant weighed 2220 g at birth and had normal Apgar scores (7 at 1 min and 8 at 5 min) and normal cord pH. She cried spontaneously shortly after delivery and breathing occurred in response to tactile stimulation. She was unable to establish sufficient spontaneous respiration and was intubated and mechanically ventilated at 1 h of age. At 3 days of age, the infant still had not established spontaneous respiration, did not respond to a CO 2 challenge and received a permanent tracheostomy to facilitate long-term mechanical ventilation.
Discussion
Congenital central hypoventilation syndrome is a rare condition, affecting an estimated 1 per 200 000 live births, and has a high mortality rate (38%). 1 The median age at death is around 3 months of age. CCHS most commonly occurs as an isolated condition (80%), but may also be associated with Hirschsprung's disease (13% of cases), neural crest cell tumors and growth hormone deficiency. 1 The CCHS in this infant appears to be an isolated finding. This case is the first reported instance in which fetal CCHS has been diagnosed in utero by molecular genetic analysis of amniocytes. Both the affected mother and the fetus were heterozygous for the PHOX2b mutation, both had approximately the same number of polyalanine repeats and both are severely affected.
Fetal breathing movements are a normal physiological phenomenon in the developing mammalian fetus 6 and are present in the human fetus from about 12 weeks' gestation onward. 7 Fetal breathing movements are not continuous but rather episodic. The periodicity is primarily regulated by sleep/wake cycle modulation of respiratory center neurons. 8 Fetal breathing movements are present almost continuously during episodes of high voltage, low frequency EEG and rapid eye movement (active sleep) and are either absent or very infrequent during low voltage, high frequency EEG discharge (quiet sleep). In this fetus with proven CCHS, there was a normal correlation between fetal sleep state, as expressed by the presence or absence of rapid eye movements, and the periodicity and character of observed fetal breathing movements. These observations suggest that in the affected fetus, the respiratory regulatory center remains responsive to sleep/wake cycle modulation.
The periodicity, frequency and character of fetal breathing movements vary with gestational age. By 32 weeks, the gestational age at which extended fetal observations began in this case, breathing movements should be present for about 40% of the time per se and are generally regular in character. A principle of fetal development is that normal anatomical development depends on normal physiological expression. Absent or restricted fetal chest wall movement is associated with pulmonary hypoplasia. 9 As infants with CCHS do not show pulmonary hypoplasia, it could be reasonably assumed that normal breathing movements must be present in utero. This case confirms this supposition: breathing movements in this fetus known to have CCHS were essentially normal in periodicity, frequency and character. These observations imply that in the individual affected with CCHS, the development and expression of the intrinsic respiratory signals are normal.
In the normal fetus, modest hypercapnea stimulates a highly significant and dramatic increase of both the amount of time the fetus spends breathing and the respiratory rate. 10 In this fetus with CCHS, modest hypercapnea, induced by a short duration of maternal apnea, did not initiate breathing or tachypnea. These observations imply that the physiological defect in the affected fetus is the same as observed after delivery.
The observation that fetal breathing movements are normal in the fetus with CCHS offers an insight into some aspects of the primary pathophysiology of the condition. These observations suggest that affected individuals have a fetal form of respiratory signaling. The inability of the respiratory center to respond to hypercapnea (and presumably also hypoxemia) is inconsequential for the fetus but is potentially lethal after birth.
